Stage 4 Prostate Cancer patients typically do not achieve remission with standard chemotherapy regimens and testosterone blocking agents, such as Lupron, that are used to slow down the development of stage 4 prostate cancer. Moreover, a major side effect of Lupron and other similar agents is breast growth and tenderness; this and other estrogen dominate related side effects can harmfully impact men’s overall long term health, energy and vitality. These common regimens are typically followed with radiation to spot treat the bone metastatic sites in an effort to improve quality of life for stage 4 prostate cancer. In fact, tumor boards and hospital cancer discussion panels are typically limited to palliative radiotherapy for stage 4 prostate cancer patients. In short, stage 4 prostate cancer has been in desperate need of new innovative approaches like gene targeted chemotherapy for quite some time. There have been definite improvements in early prostate cancer treatments like robotic surgery and less invasive techniques including cyber-knife. Let us share with you a better approach to stage 4 prostate cancer. We will also discuss key Immunotherapy cancer treatment options that are essential for stage 4 prostate cancer.
Envita is an international Cancer Center offering more options to our patients
MR-HIFU Will Change the World of Cancer and Prostate Cancer Treatment Not Yet Available in the US and this video explains why. This technology will replace much of radiation treatments, plus surgical treatments we believe in the future and it allows for real time tumor destruction (with one-two days) and treatment of Bones metastasis without harming the immune system. It will allow direct targeting of chemotherapy agents over tumors like photodynamic but more precision and targeting.
Envita’s Stage 4 Prostate Cancer Solutions in Effect
Envita’s stage 4 prostate treatments and solutions are innovative and incorporate world class technology. Not long ago, an FDA approved vaccine called Provenge was presented, using 15 year old dendritic cell technology, similar to that touted by the Germans, and used in Asian countries to battle cancer. This is what we call dendritic cell immunotherapy and it plays a critical role with regard to stage 4 prostate cancer patients. However, we think the technology is outdated and we will show you why.
In 2006, Envita’s research team developed what we call “the world’s first intelligent cancer treatment,” which actually processes the latest advancements in Natural Killer (NK) Cell Immunotherapy to assist stage 4 prostate cancer patients. Envita’s proprietary and innovative solutions may help stage 4 prostate cancer patients attain significant results. The crucial point is that Natural Killer Cells are the key. Even dendritic cell vaccines work by passing information over to the NK cells, AAIT actually provides a final product that does the tumor kill for stage 4 prostate cancer patients. Billions of targeted NK cells are ready to destroy tumors and more importantly metastasis. Here is data to review on AAIT and stage 4 prostate cancer.
Common Bone Metastasis Solutions for Stage 4 Prostate Cancer
We now assert that new dynamic innovations using high-intensity, focused ultrasound, will soon replace some radiotherapy used to treat bone cancers, especially metastatic bone stage 4 prostate cancer, bone metastasis is commonly found in prostate and breast cancer, as well as other late stage cancers. This stellar technology allows for the destruction of cancer with only one or two treatments, and without the use of radiation. This is critical as it can spare patients’ additional physical weakening and the weakening of their immune systems. Via MRI, during treatment, it is visible to see the tumor destruction instantly. Philips HIFU is a great place for you to learn more about Envita’s technology being made available to stage 4 prostate cancer patients. This, in many cases, eliminates most radiation treatments in the future, most importantly, giving direct real time imaging to see tumor destruction.
Here is another version of HIFU used in earlier stage prostate cancer. This is why Envita offers international care so you can have access to the best treatments in the world.
Vital, Independent Factors in Stage 4 Prostate Cancer: Environment of the Host
It is necessary to maintain focus on the primary causes that nourish cancer, these are epigenetic, environmental and genetic factors. Other factors may include infection, toxicity, hormone imbalances, genetic hormonal shifts, plus inflammation that feed the growth of stage 4 prostate cancer and really most other cancers.